Stephen R. Saklad, Pharm.D., BCPP

Stephen R. Saklad, PharmD, BCPP The University of Texas

Stephen R. Saklad, Pharm.D., BCPP

Director
Psychiatric Pharmacy Program
Pharmacotherapy Education and Research Center
UT Health Science Center San Antonio

Clinical Professor
Pharmacotherapy Division
The University of Texas at Austin College of Pharmacy

Adjoint Professor
School of Medicine
Pharmacotherapy Education and Research Center
UT Health Science Center San Antonio

Clinical Pharmacologist
San Antonio State Hospital
Texas Department of State Health Services


Presentation I: Psychotropic New Drug Update

Presentation II: Managing Breakthrough Symptoms in Patients with Schizophrenia Currently Treated with Long-Acting Injectable (LAI) Antipsychotics


Bio:

Dr Saklad joined the faculty of The University of Texas College of Pharmacy and the staff of San Antonio State Hospital in 1979. He has focused on providing the excellent teaching and pharmaceutical care to improve the quality of life and function in the serious and persistently mentally ill.

He wrote and successfully lobbied for the creation of a clinical research unit at San Antonio State Hospital funded by the Texas Legislature and governed by the College of Pharmacy, Department of Psychiatry and San Antonio State Hospital. He developed the first websites for The University of Texas College of Pharmacy in 1994 and the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997.

He is Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, Founding Member of CPNP, served on the CPNP Board of Directors, and was the founding senior editor of their journal, the Mental Health Clinician. He has served as the clinical chair of The University of Texas Psychiatric Pharmacotherapy Update since 2005. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions.

He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and Teaching Excellence Award from the UT College of Pharmacy in 2013.


Disclosure: Dr. Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

  • Employee of Texas Department of Health Services San Antonio
  • Speakers Bureau: Actavis, Otsuka, Sunovion
  • Consultant: Janssen, Jazz, Otsuka, Teva
  • Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Review of Conflicts Policy:  The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming.  For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director.  If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.


ACPE LogoThe University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy